Tarsus Pharmaceuticals Inc (TARS) — Financial Flexibility Index
Tarsus Pharmaceuticals Inc (TARS) has a Financial Flexibility Index of -0.08x as of March 2026. Free cash flow of $-18.83 Million (operating CF $-24.65 Million minus capex $5.82 Million) represents 0% of total liabilities ($232.18 Million). Check TARS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tarsus Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Tarsus Pharmaceuticals Inc across 8 annual periods. See working capital position of Tarsus Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tarsus Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Tarsus Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is Tarsus Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-2.59 Million | $-12.45 Million | $218.73 Million | ▲ +97.8% |
| 2024 | -0.53x | $-81.46 Million | $-83.03 Million | $152.46 Million | ▲ +67.3% |
| 2023 | -1.63x | $-111.99 Million | $-117.49 Million | $68.50 Million | ▼ -17.8% |
| 2022 | -1.39x | $-48.52 Million | $-49.03 Million | $34.96 Million | ▼ -489.9% |
| 2021 | 0.36x | $4.33 Million | $3.75 Million | $12.18 Million | ▲ +110.3% |
| 2020 | -3.45x | $-20.68 Million | $-21.14 Million | $5.99 Million | ▼ -6246.8% |
| 2019 | -0.05x | $-3.50 Million | $-3.67 Million | $64.32 Million | ▲ +82.7% |
| 2018 | -0.31x | $-1.18 Million | $-1.18 Million | $3.74 Million | — |